US Bancorp

US Bancorp Portfolio holdings

AUM $85.3B
1-Year Est. Return 19.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+19.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$85.3B
AUM Growth
+$978M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,220
New
Increased
Reduced
Closed

Top Buys

1 +$272M
2 +$126M
3 +$49.2M
4
META icon
Meta Platforms (Facebook)
META
+$40.2M
5
VT icon
Vanguard Total World Stock ETF
VT
+$36.9M

Top Sells

1 +$265M
2 +$201M
3 +$122M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$72.2M
5
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$68.3M

Sector Composition

1 Technology 13.94%
2 Financials 7.93%
3 Healthcare 5.97%
4 Industrials 4.96%
5 Communication Services 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
4151
Seres Therapeutics
MCRB
$82.6M
-12
MDXG icon
4152
MiMedx Group
MDXG
$669M
-200
METCB icon
4153
Ramaco Resources Class B
METCB
$802M
-1
MRC
4154
DELISTED
MRC Global
MRC
-403
MRUS
4155
DELISTED
Merus
MRUS
-3,993
MSDL icon
4156
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
-3,707
MTAL
4157
DELISTED
Metals Acquisition
MTAL
-295
MTRX icon
4158
Matrix Service
MTRX
$308M
-761
MXCT icon
4159
MaxCyte
MXCT
$83.5M
-86,700
NAIL icon
4160
Direxion Daily Homebuilders & Supplies Bull 3X Shares
NAIL
$373M
0
NBH
4161
Neuberger Municipal Fund Inc
NBH
$307M
-4,803
NCA icon
4162
Nuveen California Municipal Value Fund
NCA
$307M
-25,867
NCMI icon
4163
National CineMedia
NCMI
$331M
-325
NDLS icon
4164
Noodles & Co
NDLS
$35.1M
-3,625
NEXT icon
4165
NextDecade
NEXT
$1.49B
-3,890
NGD
4166
New Gold Inc
NGD
$8.88B
-700
NMAI icon
4167
Nuveen Multi-Asset Income Fund
NMAI
$436M
-2,500
NXC
4168
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
-11,034
NXTG icon
4169
First Trust Indxx NextG ETF
NXTG
$428M
-70
OBDC icon
4170
Blue Owl Capital
OBDC
$5.73B
-11,310
OCSL icon
4171
Oaktree Specialty Lending
OCSL
$1.01B
-91
ODP
4172
DELISTED
ODP
ODP
-895
OMER icon
4173
Omeros
OMER
$818M
-50
OPRX icon
4174
OptimizeRx
OPRX
$126M
-21
ORIC icon
4175
Oric Pharmaceuticals
ORIC
$1.54B
-34